Half the time, same effect? new study tests shorter light therapy for scalp lesions
NCT ID NCT07290959
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a 1-hour indoor light treatment works as well as the standard 2-hour version for actinic keratosis (scaly sun-damaged spots) on the scalp. Fifty-five adults with multiple lesions received both durations on different sides of their scalp. Researchers measured how many spots cleared up after 3 and 6 months, along with pain and skin reactions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- methyl aminolevulinate (MAL) cream with white LED light
- What this could lead to
- If successful, this could make indoor daylight PDT more convenient by halving the treatment time, potentially improving patient comfort and clinic efficiency.
- What could go wrong
- This is a small, completed study with only 55 participants, so results may not apply to everyone. Shorter exposure might be less effective for some lesions, and individual responses can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS (AK) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ospedale San Salvatore
L’Aquila, 67100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a reformulated gel plus light therapy better tackle precancerous skin spots?
- Can a five-day ointment improve sun-damaged skin? new study investigates
- New cream could zap precancerous skin spots
- Can a special sunscreen stop skin spots from turning dangerous?
- New ointment for Sun-Damaged skin spots enters early human testing
- Simple cream may shield transplant patients from skin cancer